USCBC logo

Search

Menu

Close

Member Exclusive

The Rise of US-China Biotech Partnerships: Opportunities and Emerging Challenges

China Market Intelligence Banny Wang, June Xu

Key Takeaways

  • Chinese biotech companies are becoming critical partners to American firms in early-stage drug development.
  • MNCs maintain competitive advantages throughout innovative drug lifecycles, particularly in navigating global regulatory frameworks and leveraging resources during commercialization phases.
  • US restrictions on bilateral biotech collaborations could limit these growth opportunities and weaken US pharmaceutical MNCs’ competitiveness.

This content is exclusive to USCBC members only.

Sign In

Join USCBC to read further.

register now